Toward the establishment of a clinical prediction rule for response of prolactinomas to cabergoline

J Clin Endocrinol Metab. 1999 Dec;84(12):4746-7. doi: 10.1210/jc.84.12.4746-a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cabergoline
  • Ergolines / therapeutic use*
  • Humans
  • Pituitary Neoplasms / drug therapy*
  • Prolactinoma / drug therapy*

Substances

  • Antineoplastic Agents
  • Ergolines
  • Cabergoline